RSS

Nemaura Pharma

According to a recent clinical trial performed by Nemaura Pharma on type 1 diabetic patients, its Memspatch Insulin Micro-needle Device (IMD) may offer relief to patients with a fear of needles and injections. more

19 May 2017 12:12 News